Today's Insider Trading Highlights — May 08, 2026
📅 Published: May 08, 2026 at 12:09 PM UTC
2 Cluster Buys5 Insider Purchases
On May 08, 2026, we detected 2 new cluster buys including a $5.3M purchase in $GEHC by 3 insiders, and 5 notable insider purchases. Tether Global Investments Fund, S.I.C.A.F., S.A. (10% Owner) bought $23.6M of $GOLD. Data sourced from SEC Form 4 filings analyzed by Average Insider.
⚠️ For information purposes only. This information is provided for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other type of advice. All investments carry risk, including the potential loss of principal. Past performance is not indicative of future results. You should consult with a qualified financial advisor, accountant, or other professional before making any investment decisions. The information contained in this newsletter is not intended to be a substitute for professional financial advice.
📊 Insider Trading Insights — May 08, 2026
Tracking insider purchases and cluster buys over the past 7 days. Insider buying can indicate confidence in a company's future, while cluster buys (multiple insiders buying around the same time) are particularly noteworthy signals.
🔥 Cluster Buys
$61.34
Current Price
52W: $58.75 – $89.77
$172.60
Fair Value
Participants 3 insiders | Total Shares 85,115 | Total Value $5,262,350 |
Timeframe 5 days | Date Range May 01, 2026 – May 06, 2026 |
👥 Participant Details
P&L: +1.2% (+$2,450) |
P&L: -0.9% ($43,497) | ||||
P&L: -0.6% ($349) |
📊 Valuation & Analyst Info
Fair Value: $172.60 (+181.4% undervalued vs current price)
P/E Ratio: 18.0 (0.5x below Medical - Healthcare Information Services avg (33.7)) (0.3x below Healthcare avg (26.6))
Analyst Consensus: Buy
Price Target: $84.00 (Low: $65.00 | High: $105.00 | Median: $85.00)
📰 Recent News (Last 7 Days)
$20.75
Current Price
52W: $18.01 – $36.80
$83.31
Fair Value
Participants 4 insiders | Total Shares 89,489 | Total Value $1,875,225 |
Timeframe 3 days | Date Range May 04, 2026 – May 07, 2026 |
👥 Participant Details
P&L: -3.1% ($24,115) |
P&L: -2.0% ($5,331) | ||||
P&L: +2.9% (+$9,594) |
P&L: +0.3% (+$1,524) |
📊 Valuation & Analyst Info
Fair Value: $83.31 (+301.5% undervalued vs current price)
P/E Ratio: 24.9 (0.6x below Medical - Care Facilities avg (61.8)) (0.1x below Healthcare avg (26.6))
Analyst Consensus: Buy
Price Target: $32.38 (Low: $26.00 | High: $39.00 | Median: $31.00)
📰 Recent News (Last 7 Days)
💰 Individual Insider Buys
$43.51
Current Price
52W: $19.39 – $66.70
$69.18
Fair Value
Transaction Date May 05, 2026 | Shares 530,338 | Purchase Price $44.50 |
Purchase Value $23,600,041 |
P&L: -2.2% ($525,035)
📊 Valuation & Analyst Info
Fair Value: $69.18 (+59.0% undervalued vs current price)
P/E Ratio: 30.3 (0.2x below Financial - Capital Markets avg (38.2)) (0.1x above Financial Services avg (27.2))
Analyst Consensus: Buy
Price Target: $54.00 (Low: $52.00 | High: $57.00 | Median: $53.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-09-08
$61.34
Current Price
52W: $58.75 – $89.77
$172.60
Fair Value
Transaction Date May 06, 2026 | Shares 80,805 | Purchase Price $61.88 |
Purchase Value $5,000,076 |
P&L: -0.9% ($43,497)
📊 Valuation & Analyst Info
Fair Value: $172.60 (+181.4% undervalued vs current price)
P/E Ratio: 18.0 (0.5x below Medical - Healthcare Information Services avg (33.7)) (0.3x below Healthcare avg (26.6))
Analyst Consensus: Buy
Price Target: $84.00 (Low: $65.00 | High: $105.00 | Median: $85.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-07-29
RA CAPITAL MANAGEMENT, L.P.
Director
$25.74
Current Price
52W: $23.48 – $36.61
Transaction Date May 04, 2026 | Shares 133,750 | Purchase Price $18.00 |
Purchase Value $2,407,500 |
P&L: +43.0% (+$1,035,225)
📰 Recent News (Last 7 Days)
RA CAPITAL MANAGEMENT, L.P.
Director
$25.74
Current Price
52W: $23.48 – $36.61
Transaction Date May 05, 2026 | Shares 87,143 | Purchase Price $24.59 |
Purchase Value $2,142,846 |
P&L: +4.7% (+$100,214)
📰 Recent News (Last 7 Days)
$13.64
Current Price
52W: $11.66 – $32.22
$6.84
Fair Value
Transaction Date May 06, 2026 | Shares 157,801 | Purchase Price $13.49 |
Purchase Value $2,128,735 |
P&L: +1.1% (+$23,670)
📊 Valuation & Analyst Info
Fair Value: $6.84 (-49.9% overvalued vs current price)
P/E Ratio: 63.1 (0.1x below Software - Application avg (74.2)) (0.3x above Technology avg (49.8))
Analyst Consensus: Buy
Price Target: $20.85 (Low: $14.00 | High: $30.00 | Median: $18.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-08-04
⚠️ Important Disclaimers
Investment Disclaimer: This content is for informational purposes only and should not be considered investment advice.
Data Accuracy: All information is sourced from SEC filings and third-party data providers. Errors or omissions may occur.
Market Risks: Past insider buying activity does not guarantee future performance.
Professional Advice: Consult with qualified financial professionals before making any investment decisions.
📚 Deep Dive Resources
Data sourced from SEC filings. This is for informational purposes only.
Want to receive these newsletters in your inbox? Sign up here